Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 138 entries
View as:

A Study Comparing Two Fluticasone Furoate Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT01279057 Org: User:
Start: 12/27/10 End: 02/08/11 Due: 02/08/12

Randomized, Controlled, Double-blind Multicenter Safety Study to Evaluate the Safety and Immunogenicity of Subcutaneous EPO HEXAL vs. ERYPO® in the Treatment of Anemia Associated With Chronic Renal Insufficiency in Predialysis Patients

Phase: N/A Priority: Normal
NCT ID: NCT00701714 Org: User:
Start: 09/30/07 End: 01/31/10 Due: 01/31/11

GP2013 Treatment in Patients With Active Rheumatoid Arthritis, Previously Treated With Rituxan® or MabThera®

Phase: N/A Priority: Normal
NCT ID: NCT02514772 Org: User:
Start: 07/31/15 End: 10/31/16 Due: 10/31/17

A Randomized, Phase I/II Trial to Assess the Safety and Antiviral Effects of Escalating Doses of A Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Viremia and/or Viruria

Phase: N/A Priority: Normal
NCT ID: NCT00002268 Org: User:
Start: - End: - Due: -

A Relative Bioavailability Study of 75mg Indomethacin Extended-Release Capsules

Phase: N/A Priority: Normal
NCT ID: NCT00858195 Org: User:
Start: 06/30/06 End: 07/31/06 Due: 07/31/07

A Multicenter Placebo-Controlled Dose Titration Study to Evaluate the Efficacy and Safety of Sandostatin (SMS 201-995) in the Treatment of Patients With Acquired Immunodeficiency Related Diarrhea

Phase: N/A Priority: Normal
NCT ID: NCT00002252 Org: User:
Start: - End: - Due: -

GP2013 in the Treatment of RA Patients Refractory to or Intolerant of Standard Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01274182 Org: User:
Start: 01/31/11 End: 11/30/16 Due: 11/30/17

To Demonstrate the Relative Bioequivalency of Comparing Single 100 mg Doses Of Cord's 50 mg Desipramine HCL Tablets To Merrell Dow's 50 mg Norpramin Tablets

Phase: N/A Priority: Normal
NCT ID: NCT00914004 Org: User:
Start: - End: - Due: -

Pilot Study to Examine the Post-Dose Changes in Exhaled Nitric Oxide (eNO) Following Treatment With Fluticasone Propionate (FP)/Salmeterol (SAL) Combination Product Advair

Phase: N/A Priority: Normal
NCT ID: NCT00927758 Org: User:
Start: 06/30/09 End: 12/31/09 Due: 12/31/10

To Demonstrate the Relative Bioavailability of Atenolol Tablets

Phase: N/A Priority: Normal
NCT ID: NCT00913965 Org: User:
Start: 07/31/89 End: 08/31/89 Due: 08/31/90

This Was a Clinical Study Investigating the Moisturization and Desquamation Effect of AmLactin® Rapid Relief Restoring Lotion + Ceramides on Dry Skin in Healthy Female Volunteers. AmLactin® Rapid Relief is an Over-the-counter Cosmetic

Phase: N/A Priority: Normal
NCT ID: NCT04085809 Org: User:
Start: 03/26/19 End: 04/08/19 Due: 04/08/20

To Demonstrate the Relative Bioavailability of Cefzil 250 mg/5 ml Cefprozil Oral Suspension Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00881400 Org: User:
Start: 06/30/04 End: 06/30/04 Due: 06/30/05

Comparative Bioavailability Study of Azithromycin 200mg/5mL Suspension Following a 600mg Dose Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00875966 Org: User:
Start: 08/31/04 End: 10/31/04 Due: 10/31/05

Study of the Safety of Use of Intravitreal SOK583A1 Provided in a Vial Kit

Phase: N/A Priority: Normal
NCT ID: NCT05282004 Org: User:
Start: 05/16/22 End: 09/07/22 Due: 09/07/23

Comparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00865176 Org: User:
Start: 06/30/06 End: 07/31/06 Due: 07/31/07

Study of LRG-002 Hard Capsules (Lek d.d., Slovenia) Used in the Prophylaxis of Antibiotic-associated Diarrhea in Adults.

Phase: N/A Priority: Normal
NCT ID: NCT04321460 Org: User:
Start: 10/01/20 End: 01/04/21 Due: 01/04/22

To Demonstrate the Relative Bioavailability of Alprazolam Tablets, 2 mg

Phase: N/A Priority: Normal
NCT ID: NCT00912145 Org: User:
Start: 02/29/96 End: 02/29/96 Due: 02/28/97

A Study to Compare Efficacy, Safety, and Immunogenicity of GME751 and EU-authorized Keytruda in Adult Participants With Untreated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT06159790 Org: User:
Start: 04/29/24 End: 12/31/25 Due: 12/31/26

Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta®

Phase: N/A Priority: Normal
NCT ID: NCT01735175 Org: User:
Start: 06/30/12 End: 02/28/14 Due: 02/28/15

Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim

Phase: N/A Priority: Normal
NCT ID: NCT01519700 Org: User:
Start: 12/31/11 End: 06/30/13 Due: 06/30/14

To Demonstrate the Relative Bioavailability of Divalproex Sodium 500 mg Delayed Release Tablets Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00913874 Org: User:
Start: 10/31/05 End: 10/31/05 Due: 10/31/06

A Crossover Bioequivalence Study of Olaparib Tablets, 150 mg (Lek Pharmaceuticals d.d.) and Lynparza® (Olaparib) Tablets 150 mg (AstraZeneca Pharmaceuticals LP), in Patients With Breast Cancer Gene (BRCA) Mutated Ovarian Cancer, Recurrent Ovarian Cancer or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05258747 Org: User:
Start: 04/07/22 End: 10/20/22 Due: 10/20/23

An Open, Randomised, Single Dose, 2-period, 2-sequence Crossover Adhesion Study of Two Different Transdermal Patches Containing Rotigotine.

Phase: N/A Priority: Normal
NCT ID: NCT04183634 Org: User:
Start: 12/03/19 End: 03/16/20 Due: 03/16/21

To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicel 300 mg Capsule Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00882154 Org: User:
Start: 04/30/05 End: 04/30/05 Due: 04/30/06

Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim

Phase: N/A Priority: Normal
NCT ID: NCT01516736 Org: User:
Start: 03/31/12 End: 12/31/13 Due: 12/31/14